Replies to post #174032 on Cytodyn Inc (CYDY)

[7realone7]

Quote:
"Well, except that is not quite the case. The science for HIV treatment is good by most accounts, the subbrackets in the Covid test, under 50 was statistically significant."

Brazil trials will pan out nicely without the ridiculous 2 dosage restriction.

[ClosetInvestor]

“What is clear is management is incompetent and spending is way out of control for a company at this stage, which when combines with microraises of money, keeps it in a perpetual state of near disaster.”

Probably one of the best descriptions of management and CYDY that I’ve seen. Leronlimab has so much potential but is being held back from the podium by mismanagement at all levels, financing, trials design, operations, etc.

[kevindenver]

Thanks, so it was HIV as the initial draw. That seems to be a prime example of bad management for sure with that harsh FDA rejection, and then on the Covid front a scolding on how the company tried to adjust their claims.

Think there is evidence that LL works, however incomplete.

Where? and who cares as incomplete is WORTHLESS! Especially when they can't even fill out the applications correctly let alone succeed.